We're Moving to Revvity.com
Visitors from the United States and Canada can now explore, discover, and buy our products and services at Revvity.com. You will be automatically redirected to Revvity.com
Not located in the United States or Canada?
Genhance on the ASK
Overview
Genhance™ agents are small molecule fluorescent agents that can be used as a control or in vascular permeability imaging/blood pooling. Genhance enables imaging of circulation, blood vessels, and the vasculature. It is typically imaged using intravital microscopy (IVM). Genhance™ 680 is the acid form of VivoTag® 680 and Genhance™ 750 is the acid form of VivoTag® 750. Both agents come in two sizes (1 mg and 5 mg).
Products and catalog numbers
| Product | Catalog Number | Ex/Em wavelength (nm) | Molecular weight (g/mol) | Validated Experiments | Applications | Storage and Stability |
|---|---|---|---|---|---|---|
| Genhance 680
(1 mg) | NEV10117 | 670/688 | ~ 1646 | In vivo | Control
Vascular | Technical Data Sheet |
| Genhance 680
(5 mg) | NEV10130 | 670/688 | ~ 1646 | In vivo | Control
Vascular | Technical Data Sheet |
| Genhance 750
(1 mg) | NEV10118 | 750/775 | 1086 | In vivo | Control
Vascular | Technical Data Sheet |
| Genhance 750
(5 mg) | NEV10177 | 750/775 | 1086 | In vivo | Control
Vascular | Technical Data Sheet |
Using Genhance in vivo
| Genhance | Route of Injection | Mouse Dose (25 g) | Rat Dose (250 g) | Blood t 1/2 | Tissue t 1/2 | Optimal imaging time | Optimal Re-injection Time (complete clearance) | Route of Metabolism/ background tissue | FMT& IVIS settings |
|---|---|---|---|---|---|---|---|---|---|
| Genhance 680 | IV | 50 ug | 150-500 ug | 0.5 h | not determined | 0.5 h | not determined | Bladder | FMT 680/700
IVIS 675/720 |
| Genhance 750 | IV | 50 ug | 150-500 ug | 0.5 h | not determined | 0.5 h | not determined | Bladder | FMT 750/770
IVIS 745/800 |
Citations
Please visit our Citations Library for references using Genhance on the IVIS or on the FMT.
- Application Support Knowledge Base Home
- In Vivo and Preclinical Imaging
- Acute inflammation preclinical and in vivo imaging
- Angiogenesis on the ASK
- Arthritis on the ASK
- Atherosclerosis on the ASK
- Bacterial Infection on the ASK
- Bone biology and preclinical imaging
- Oncology on the ASK
- Pulmonary inflammation and preclinical imaging
- Vascular disease on the ASK
- Bioluminescent Cell Lines
- Light-producing microbes on the ASK
- RediFect lentiviral particles for in vivo and ex vivo imaging
- Luciferin and Coelenterazine Substrates
- Activatable imaging agents on the ASK
- Targeted in vivo agents on the ASK
- Vascular in vivo agents on the ASK
- AngioSense on the ASK
- AngioSPARK on the ASK
- Annexin Vivo on ASK
- Bacterial Detection Probe on the ASK
- BacteriSense on the ASK
- BombesinRSense on the ASK
- CAT B FAST on the ASK
- CAT K FAST on the ASK
- COX-2 probe on the ASK
- FolateRSense on the ASK
- GastroSense on the ASK
- Genhance on the ASK
- GFR-Vivo on the ASK
- HypoxiSense on the ASK
- IntegriSense on the ASK
- MMPSense on the ASK
- Neutrophil Elastase on the ASK
- OsteoSense on the ASK
- ProSense on the ASK
- PSA FAST on the ASK
- Rediject 2-DG on the ASK
- ReninSense on the ASK
- Superhance on the ASK
- TLectinSense on the ASK
- Transferrin-Vivo 750 on the ASK
- VivoTag on the ASK
- Depilation on the ASK
- IP injections for NIRF agents on ASK
- Lateral tail vein injections on the ASK
- Radioimaging on the ASK